The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2023

Regulation 3(3)

SCHEDULE 2Amendment to Annex 6

This schedule has no associated Explanatory Memorandum

“33	1,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone	Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine	919803-06-8	485-100-6	10%	In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %.
						Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation.
34	1,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone	Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano)	919803-06-8	485-100-6	10%	Only nanomaterials having the following characteristics are allowed:
						Purity ≥ 97 %, Median particle size D50 (50 % of the number below this diameter): ≥ 50 nm of number size distribution.
						Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation.
						In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %. ”